Literature DB >> 20819167

TDP-43 proteinopathy in familial motor neurone disease with TARDBP A315T mutation: a case report.

N J Cairns, R J Perrin, R E Schmidt, A Gru, K G Green, D Carter, L Taylor-Reinwald, J C Morris, M A Gitcho, R H Baloh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20819167      PMCID： PMC2978282          DOI： 10.1111/j.1365-2990.2010.01121.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN： 0305-1846            Impact factor:   8.090


× No keyword cloud information.
  26 in total

Review 1.  Genetic aspects of amyotrophic lateral sclerosis.

Authors:  Teepu Siddique; Irfan Lalani
Journal:  Adv Neurol       Date:  2002

2.  Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia.

Authors:  G Wightman; V E Anderson; J Martin; M Swash; B H Anderton; D Neary; D Mann; P Luthert; P N Leigh
Journal:  Neurosci Lett       Date:  1992-05-25       Impact factor: 3.046

3.  New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis.

Authors:  K Okamoto; S Hirai; T Yamazaki; X Y Sun; Y Nakazato
Journal:  Neurosci Lett       Date:  1991-08-19       Impact factor: 3.046

4.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

5.  The overlap of amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Catherine Lomen-Hoerth; Thomas Anderson; Bruce Miller
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

6.  Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation.

Authors:  Maria I Behrens; Odity Mukherjee; Pang-hsien Tu; Rajka M Liscic; Lea Tenenholz Grinberg; Deborah Carter; Katherine Paulsmeyer; Lisa Taylor-Reinwald; Michael Gitcho; Joanne B Norton; Sumi Chakraverty; Alison M Goate; John C Morris; Nigel J Cairns
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Jan-Mar       Impact factor: 2.703

Review 7.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.

Authors:  Nigel J Cairns; Manuela Neumann; Eileen H Bigio; Ida E Holm; Dirk Troost; Kimmo J Hatanpaa; Chan Foong; Charles L White; Julie A Schneider; Hans A Kretzschmar; Deborah Carter; Lisa Taylor-Reinwald; Katherine Paulsmeyer; Jeffrey Strider; Michael Gitcho; Alison M Goate; John C Morris; Manjari Mishra; Linda K Kwong; Anna Stieber; Yan Xu; Mark S Forman; John Q Trojanowski; Virginia M-Y Lee; Ian R A Mackenzie
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

9.  Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

Authors:  Ian R A Mackenzie; Eileen H Bigio; Paul G Ince; Felix Geser; Manuela Neumann; Nigel J Cairns; Linda K Kwong; Mark S Forman; John Ravits; Heather Stewart; Andrew Eisen; Leo McClusky; Hans A Kretzschmar; Camelia M Monoranu; J Robin Highley; Janine Kirby; Teepu Siddique; Pamela J Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088
View more
  7 in total

Review 1.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

2.  Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS.

Authors:  Patricia S Estes; Ashley Boehringer; Rebecca Zwick; Jonathan E Tang; Brianna Grigsby; Daniela C Zarnescu
Journal:  Hum Mol Genet       Date:  2011-03-26       Impact factor: 6.150

3.  An ALS-mutant TDP-43 neurotoxic peptide adopts an anti-parallel β-structure and induces TDP-43 redistribution.

Authors:  Li Zhu; Meng Xu; Mengxue Yang; Yanlian Yang; Yang Li; Jianwen Deng; Linhao Ruan; Jianghong Liu; Sidan Du; Xuehui Liu; Wei Feng; Kazuo Fushimi; Eileen H Bigio; Marsel Mesulam; Chen Wang; Jane Y Wu
Journal:  Hum Mol Genet       Date:  2014-08-11       Impact factor: 6.150

4.  Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.

Authors:  David J Irwin; Nigel J Cairns; Murray Grossman; Corey T McMillan; Edward B Lee; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2014-12-31       Impact factor: 17.088

Review 5.  The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum.

Authors:  Tim Van Langenhove; Julie van der Zee; Christine Van Broeckhoven
Journal:  Ann Med       Date:  2012-03-16       Impact factor: 4.709

6.  TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.

Authors:  Ching-Chieh Chou; Yi Zhang; Mfon E Umoh; Spencer W Vaughan; Ileana Lorenzini; Feilin Liu; Melissa Sayegh; Paul G Donlin-Asp; Yu Han Chen; Duc M Duong; Nicholas T Seyfried; Maureen A Powers; Thomas Kukar; Chadwick M Hales; Marla Gearing; Nigel J Cairns; Kevin B Boylan; Dennis W Dickson; Rosa Rademakers; Yong-Jie Zhang; Leonard Petrucelli; Rita Sattler; Daniela C Zarnescu; Jonathan D Glass; Wilfried Rossoll
Journal:  Nat Neurosci       Date:  2018-01-08       Impact factor: 24.884

7.  The D2 Dopamine Receptor Interferes With the Protective Effect of the A2A Adenosine Receptor on TDP-43 Mislocalization in Experimental Models of Motor Neuron Degeneration.

Authors:  Chia-You Lai; Yu-Ju Liu; Hsing-Lin Lai; Hui-Mei Chen; Hung-Chi Kuo; Yu-Ping Liao; Yijuang Chern
Journal:  Front Neurosci       Date:  2018-03-20       Impact factor: 4.677
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.